The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study

JAMA Psychiatry.

Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulè A, Szöke A, Selten JP, Turner C, Arango C, Tarricone I, Berardi D, Tortelli A, Llorca PM, de Haan L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Murray RM, Rutten BP, Jones PB, van Os J, Morgan C, Kirkbride JB; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group

doi: 10.1001/

Anxiety and Depression

Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood: Findings from a longitudinal cohort study over 30 years

J Affect Disord.

Hengartner MP, Angst J, Ajdacic-Gross V, Rössler W

doi: 10.1016/j.jad.2020.03.126.

Epilepsy

Ultra-rare genetic variation in common epilepsies: a case-control sequencing study.

Lancet Neurol.

Epi4K consortium; Epilepsy Phenome/Genome Project.

doi: 10.1016/

Psychosis and Schizophrenia

Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies

Lancet Psychiatry

Cullen AE, Palmer-Cooper EC, Hardwick M, Vaggers S, Crowley H, Pollak TA, Lennox BR

doi: 10.1016/S2215-0366(20)30432-6

Parkinson’s DiseasePsychosis and Schizophrenia

High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.

J Clin Psychopharmacol.

Mentzel TQ, Lieverse R, Bloemen O, Viechtbauer W, van Harten PN; Genetic Risk and Outcome of Psychosis (GROUP) Investigators

doi: 10.1097/

Further Publications NeurologyFurther Publications Psychiatry

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Lancet Psychiatry.

Freeman TP, Hindocha C, Baio G, Shaban NDC, Thomas EM, Astbury D, Freeman AM, Lees R, Craft S, Morrison PD, Bloomfield MAP, O'Ryan D, Kinghorn J, Morgan CJA, Mofeez A, Curran HV

doi: 10.1016/S2215-0366(20)30290-X.

Further Publications NeurologyFurther Publications Psychiatry

The impact of the trajectory of bipolar disorder on global cognitive function: A one-year clinical prospective case-control study

J Affect Disord.

Knorr U, Miskowiak K, Akhøj M, Vinberg M, Forman J, Kessing LV

doi: 10.1016/j.jad.

Psychosis and Schizophrenia

Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence

Front Psychiatry.

Moulin V, Baumann P, Gholamrezaee M, Alameda L, Palix J, Gasser J, Conus P

doi: 10.3389/fpsyt.2018.00294.

Attention Deficit Hyperactivity Disorder (ADHD)

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases